238 related articles for article (PubMed ID: 22874673)
21. Regulation of amyloid-β production by the prion protein.
Griffiths HH; Whitehouse IJ; Hooper NM
Prion; 2012 Jul; 6(3):217-22. PubMed ID: 22449984
[TBL] [Abstract][Full Text] [Related]
22. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
23. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
24. Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.
Lewis V; Whitehouse IJ; Baybutt H; Manson JC; Collins SJ; Hooper NM
PLoS One; 2012; 7(2):e31754. PubMed ID: 22363722
[TBL] [Abstract][Full Text] [Related]
25. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
26. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
27. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
[TBL] [Abstract][Full Text] [Related]
28. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
29. Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.
Griffiths HH; Whitehouse IJ; Baybutt H; Brown D; Kellett KA; Jackson CD; Turner AJ; Piccardo P; Manson JC; Hooper NM
J Biol Chem; 2011 Sep; 286(38):33489-500. PubMed ID: 21795680
[TBL] [Abstract][Full Text] [Related]
30. α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.
Guillot-Sestier MV; Sunyach C; Ferreira ST; Marzolo MP; Bauer C; Thevenet A; Checler F
J Biol Chem; 2012 Feb; 287(7):5021-32. PubMed ID: 22184125
[TBL] [Abstract][Full Text] [Related]
31. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
[TBL] [Abstract][Full Text] [Related]
32. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
33. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
34. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
35. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
36. Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.
Lewis V; Johanssen VA; Crouch PJ; Klug GM; Hooper NM; Collins SJ
Cell Mol Life Sci; 2016 Feb; 73(3):667-83. PubMed ID: 26298290
[TBL] [Abstract][Full Text] [Related]
37. Unaltered prion protein expression in Alzheimer disease patients.
Saijo E; Scheff SW; Telling GC
Prion; 2011; 5(2):109-16. PubMed ID: 21654203
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
